Professor Savita Rangarajan

MD, FRCP; FRCPath

Professor

Connect with Savita

Email: [email protected]

ORCID

Publications

87 publications

Page 7 of 9

Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom

Charles R M Hay, Ben Palmer, Elizabeth Chalmers, Ri Liesner, Rhona Maclean, Savita Rangarajan, Michael Williams & Peter W Collins, 2011, Blood, 117(23), 6367-6370

DOI: 10.1182/blood-2010-09-308668

Type: article

Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma

L. Dai, D. Bevan, S. Rangarajan, B. Sørensen & M. Mitchell, 2011, Haemophilia, 17, e944-e948

DOI: 10.1111/j.1365-2516.2011.02491.x

Type: article

Three dominant-negative mutations in factor XI-deficient patients

L. Dai, S. Rangarajan & M. Mitchell, 2011, Haemophilia, 17(5), e919-922

DOI: 10.1111/j.1365-2516.2011.02519.x

Type: article

Experience of four UK comprehensive care centres using FEIBA^® for surgeries in patients with inhibitors

S. Rangarajan, T. T. Yee & J. Wilde, 2011, Haemophilia, 17(1), 28-34

DOI: 10.1111/j.1365-2516.2010.02360.x

Type: article

Inhibitors of coagulation

S. Rangarajan, 2011, Haemophilia, 17(1), 90-94

DOI: 10.1111/j.1365-2516.2010.02335.x

Type: article

Von Willebrand factor - two sides and the edge of a coin

S. Rangarajan, 2011, Haemophilia, 17(1), 61-64

DOI: 10.1111/j.1365-2516.2010.02323.x

Type: article

Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders

Christian Fenger-Eriksen, Gary W Moore, Savita Rangarajan, Jørgen Ingerslev & Benny Sørensen, 2010, Transfusion, 50(12), 2571-2576

DOI: 10.1111/j.1537-2995.2010.02752.x

Type: article

Molecular characterization of 11 novel mutations in patients with heterozygous and homozygous FV deficiency

J. A. Cutler, R. Patel, S. Rangarajan, R. C. Tait & M. J. Mitchell, 2010, Haemophilia, 16(6), 937-942

DOI: 10.1111/j.1365-2516.2010.02330.x

Type: article

Pharmacokinetics, coagulation factor consumption and clinical efficacy in patients being switched from full-length FVIII treatment to B-domain-deleted r-FVIII and back to full-length FVIII

C. Rea, A. Dunkerley, B. Sørensen & S. Rangarajan, 2009, Haemophilia, 15(6), 1237-1242

DOI: 10.1111/j.1365-2516.2009.02071.x

Type: article

Haemostasis screening

Gary W Moore & Savita Rangarajan, 2009, British Journal of Hospital Medicine, 70(8), M116-8

DOI: 10.12968/hmed.2009.70.Sup8.43551

Type: article

How to edit profile